Cargando…
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
BACKGROUND: Radically resected early uterine leiomyosarcoma (eULMS) is still marked by a poor prognosis. Adjuvant strategies investigated up to now have not been corroborated by controlled studies. We retrospectively reviewed the clinical outcome of eULMS patients treated with adjuvant anthracycline...
Autores principales: | Fucà, Giovanni, Fabbroni, Chiara, Mancari, Rosanna, Manglaviti, Sara, Bogani, Giorgio, Fumagalli, Elena, Bertulli, Rossella, Morosi, Carlo, Collini, Paola, Raspagliesi, Francesco, Colombo, Nicoletta, Casali, Paolo G., Sanfilippo, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456084/ https://www.ncbi.nlm.nih.gov/pubmed/32874547 http://dx.doi.org/10.1186/s13569-020-00139-3 |
Ejemplares similares
-
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma
por: Colia, Vittoria, et al.
Publicado: (2017) -
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
por: Fabbroni, Chiara, et al.
Publicado: (2021) -
High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
por: Colia, Vittoria, et al.
Publicado: (2017) -
Response of conventional chondrosarcoma to gemcitabine alone: a case report
por: Provenzano, Salvatore, et al.
Publicado: (2015) -
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2017)